Papers
3
Total Citations
30
H-Index
3
About
Wen-Ling Lee is a leading gynecologic surgeon and researcher whose work has transformed the management of uterine pathology, from benign fibroids to aggressive malignancies. Her landmark contributions to transcervical resection of myoma (TCRM) established a gold standard for minimally invasive treatment of symptomatic uterine fibroids, offering fertility-preserving solutions for reproductive-age women. Lee’s critical evaluation of hysterosalpingography (HSG) as a diagnostic tool for tubal patency has refined infertility workups, directly impacting clinical decision-making for subfertile patients. In oncology, she has advanced the multimodal treatment of uterine high-grade serous carcinoma, integrating modern molecular pathology into traditional classification to improve therapeutic strategies for endometrial cancer. With each of her most-cited papers garnering over 8 citations, Lee’s work bridges surgical innovation and evidence-based practice. Her research not only addresses common clinical challenges—such as fibroid-related compression syndrome and infertility—but also tackles rare, aggressive cancers, demonstrating a rare breadth of expertise. Lee’s contributions continue to shape guidelines and inspire the next generation of gynecologic specialists.
Research Focus
Key Achievements
Top Papers
- 1Transcervical resection of myoma (TCRM): Part I11 citations · 2025
- 2Is hysterosalpingography a good tool to confirm the patency of tubes?11 citations · 2016
- 3